Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants must have stable, documented cardiovascular disease (including at least one of the following diagnosed \> 2 months prior to the Screening visit - angina, myocardial infarction (MI), revascularization, transient ischemic attack (TIA), and peripheral vascular disease (PVD).~* Participants that smoke \> 10 cigarettes / day.~Exclusion Criteria:~* Participants with unstable cardiovascular disease~* Cardiovascular events in the past 2 months~* Moderate or severe chronic obstructive pulmonary disease (COPD)

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): None
- varenicline (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).